Trial Outcomes & Findings for Implementing mHealth for Schizophrenia in Community Mental Health Settings (NCT NCT04147897)
NCT ID: NCT04147897
Last Updated: 2025-11-24
Results Overview
The Green Paranoid Thoughts Scale (GPTS)- part B measures ideas of persecution. Scores range from 16-80. Higher scores represent more severe symptoms.
COMPLETED
NA
299 participants
0,3,6 months
2025-11-24
Participant Flow
Participant milestones
| Measure |
External Facilitation
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Enrolled in study
STARTED
|
176
|
123
|
|
Enrolled in study
Completed baseline
|
157
|
117
|
|
Enrolled in study
COMPLETED
|
157
|
117
|
|
Enrolled in study
NOT COMPLETED
|
19
|
6
|
|
3M Follow up
STARTED
|
157
|
117
|
|
3M Follow up
COMPLETED
|
101
|
85
|
|
3M Follow up
NOT COMPLETED
|
56
|
32
|
|
6M Follow Up
STARTED
|
101
|
85
|
|
6M Follow Up
COMPLETED
|
82
|
70
|
|
6M Follow Up
NOT COMPLETED
|
19
|
15
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Analyzed includes only those that completed baseline assessment
Baseline characteristics by cohort
| Measure |
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Total
n=274 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Sex/Gender, Customized
Gender · Male
|
64 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
75 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
139 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Sex/Gender, Customized
Gender · Female
|
45 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
72 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
117 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Sex/Gender, Customized
Gender · Trandgender
|
4 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
8 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Sex/Gender, Customized
Gender · Other
|
4 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
8 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Sex/Gender, Customized
Gender · Unknown
|
0 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
9 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
12 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
5 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
3 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
Black or African American
|
12 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
17 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
29 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
White
|
81 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
108 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
189 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
More than one race
|
13 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
18 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
31 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
0 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
16 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
17 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
33 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
99 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
136 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
235 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
No formal school
|
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
3 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
Grade school
|
1 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
3 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
Junior high
|
8 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
9 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
17 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
High school diploma/GED
|
72 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
109 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
181 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
Associate's degree
|
22 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
19 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
41 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
Bachelor's degree or higher
|
11 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
14 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
25 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Education
Unknown
|
0 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
1 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
1 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Age, Continuous
|
43 Years
STANDARD_DEVIATION 12 • n=45 Participants • Analyzed includes only those that completed baseline assessment
|
43.6 Years
STANDARD_DEVIATION 11.7 • n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
43.4 Years
STANDARD_DEVIATION 11.8 • n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Unable to work / Disabled
|
74 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
102 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
176 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Unemployed but looking for work
|
14 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
13 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
27 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Unemployed but not looking for work
|
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
7 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
9 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Employed full time
|
6 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
11 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
17 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Employed part time
|
14 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
12 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
26 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Student
|
5 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
7 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
12 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Employment
Retired
|
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
5 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
7 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Housing
Own/rent home or apartment
|
78 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
99 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
177 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Housing
Friend's home or apartment
|
23 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
31 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
54 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Housing
Mental health/substance use treatment facility or halfway house
|
13 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
15 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
28 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Housing
Homeless
|
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
11 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
13 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
|
Housing
Unknown
|
1 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
|
1 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
|
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Patient Health Questionnaire (PHQ)-9 is the major depressive disorder (MDD) module of the full PHQ. Total scores range from 0-27. Higher scores represent more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Patient Health Questionnaire (PHQ)-9
Baseline
|
11.6 Scores on scale
Standard Error 0.5
|
10.7 Scores on scale
Standard Error 0.6
|
|
Patient Health Questionnaire (PHQ)-9
3M Follow-up
|
9.6 Scores on scale
Standard Error 0.6
|
10.2 Scores on scale
Standard Error 0.7
|
|
Patient Health Questionnaire (PHQ)-9
6M Follow-up
|
9.3 Scores on scale
Standard Error 0.7
|
9.4 Scores on scale
Standard Error 0.7
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Generalized Anxiety Disorder-7 (GAD-7) measures generalized anxiety disorder symptoms. GAD-7 total score ranges from 0 to 21. Higher scores represent more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Generalized Anxiety Disorder-7 (GAD-7)
Baseline
|
9.3 Scores on scale
Standard Error 0.5
|
9 Scores on scale
Standard Error 0.6
|
|
Generalized Anxiety Disorder-7 (GAD-7)
3M Follow-up
|
7.6 Scores on scale
Standard Error 0.6
|
7.9 Scores on scale
Standard Error 0.6
|
|
Generalized Anxiety Disorder-7 (GAD-7)
6M Follow-up
|
7.9 Scores on scale
Standard Error 0.7
|
7.6 Scores on scale
Standard Error 0.6
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Insomnia Severity Index (ISI) is a brief screening assessment tool designed to evaluate insomnia. Total scores range from 0-28. Higher scores represent more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Insomnia Severity Index (ISI)
Baseline
|
12.4 Scores on scale
Standard Error 0.7
|
12.4 Scores on scale
Standard Error 0.6
|
|
Insomnia Severity Index (ISI)
3M Follow-up
|
11.4 Scores on scale
Standard Error 0.8
|
11.9 Scores on scale
Standard Error 0.7
|
|
Insomnia Severity Index (ISI)
6M Follow-up
|
12.6 Scores on scale
Standard Error 0.8
|
11.1 Scores on scale
Standard Error 0.7
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Green Paranoid Thoughts Scale (GPTS)- part B measures ideas of persecution. Scores range from 16-80. Higher scores represent more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Green Paranoid Thoughts Scale- Part B
3M Follow-up
|
31.6 Scores on scale
Standard Error 1.8
|
30.4 Scores on scale
Standard Error 1.6
|
|
Green Paranoid Thoughts Scale- Part B
6M Follow-up
|
32.4 Scores on scale
Standard Error 1.9
|
30.1 Scores on scale
Standard Error 1.7
|
|
Green Paranoid Thoughts Scale- Part B
Baseline
|
31.8 Scores on scale
Standard Error 1.7
|
32.5 Scores on scale
Standard Error 1.4
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Symptom Check List-9 (SCL-9) is a brief version of the SCL-90, which aims to evaluate a broad range of psychological problems and symptoms of psychopathology. Total scores are calculated as sum of all responses. Total sum scores range from 0-36. Higher scores mean more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Symptom Check List (SCL-9)
Baseline
|
13.7 Scores on scale
Standard Error 0.8
|
13 Scores on scale
Standard Error 0.9
|
|
Symptom Check List (SCL-9)
3M Follow-up
|
11.2 Scores on scale
Standard Error 0.9
|
11.7 Scores on scale
Standard Error 1.0
|
|
Symptom Check List (SCL-9)
6M Follow-up
|
10.7 Scores on scale
Standard Error 0.9
|
11.3 Scores on scale
Standard Error 1.0
|
PRIMARY outcome
Timeframe: 0,3,6 MonthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
A 9-item measure specifically designed to quantify characteristics of auditory hallucinations including frequency, negative content, loudness, duration, interference with life, distress, impact on self-appraisal, and compliance with commands. Total score is a sum of all 9 items. Total HPSVQ scores range from 0-36. Higher scores mean more severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
Baseline
|
14.3 Scores on scale
Standard Error 1.0
|
13.8 Scores on scale
Standard Error 0.9
|
|
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
3M Follow-up
|
13.6 Scores on scale
Standard Error 1.1
|
12.5 Scores on scale
Standard Error 1.0
|
|
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
6M Follow-up
|
13.0 Scores on scale
Standard Error 1.2
|
11.5 Scores on scale
Standard Error 1.0
|
PRIMARY outcome
Timeframe: 0,3,6 monthsPopulation: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).
The Illness Management and Recovery Scales (IMRS) measure illness management and recovery. Scoring is a sum of all responses ranging from 15-75. Higher scores mean less severe symptoms.
Outcome measures
| Measure |
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
|
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
|
|---|---|---|
|
Illness Management and Recovery Scales (IMRS)
Baseline
|
49.7 Scores on scale
Standard Error 0.7
|
49.8 Scores on scale
Standard Error 0.8
|
|
Illness Management and Recovery Scales (IMRS)
3M Follow-up
|
51.0 Scores on scale
Standard Error 0.8
|
50.7 Scores on scale
Standard Error 0.9
|
|
Illness Management and Recovery Scales (IMRS)
6M Follow-up
|
50.4 Scores on scale
Standard Error 0.8
|
51.2 Scores on scale
Standard Error 0.9
|
Adverse Events
External Facilitation
Internal Facilitation
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place